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       VISUAL ABSTRACT 34 
 35 
Key question: What are the immediate and long-term outcomes when using in-situ skeletonized 36 
BITAs for left coronary circulation (LCC)? 37 
 38 
 39 
Key findings: In-situ skeletonized BITAs to LCC is associated with good long-term outcomes 40 
and graft patency 41 
 42 
 43 
Take-home message: The reported surgical strategy optimizes immediate and long-term results 44 
and should be applied extensively in CABG patients. 45 
 46 
47 
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 Abstract  48 
Background. We aimed to analyze the outcomes in a patient population using a 49 
standardized technique for coronary artery bypass consisting of total arterial myocardial 50 
revascularization with in-situ skeletonized bilateral thoracic artery for left coronary 51 
circulation (ISS-LITA-LCC-TAMR). We also explored potential predictors of long-time 52 
unfavorable outcomes. 53 
Methods. Patients undergoing ISS-LITA-LCC-TAMR between January 1997 and May 54 
2017, were included prospectively in this study. Median follow-up (100% complete) 55 
was 103 months (IQR  61 to 189 months) and ranged from 1 to 245 months. 56 
Results One-thousand-three-hundred-twenty-five consecutive patients were recruited. 57 
During follow up there were 131 deaths (9.8%), 146 repeat revascularizations (11.0%) 58 
and 229 major adverse cardiac events (MACE, 17.2%). Eighteen-year freedom from 59 
these events were 62.6±9.3%,62.5±6.3% and 53.9±11.0 %, respectively.  Multivariable 60 
models showed that left ventricular ejection fraction ≤ 35%, chronic obstructive 61 
pulmonary disease, peripheral vascular disease (p<0.001), chronic kidney disease and 62 
age ≥80 years (p=0.002) were independent predictors of diminished long-term survival. 63 
Moreover, peripheral vascular disease and off-pump coronary artery bypass (both, 64 
p<0.001) predicted repeat revascularization. Finally, age ≥ 80 years, peripheral vascular 65 
disease, left ventricular ejection fraction ≤ 35%, off-pump coronary artery bypass and 66 
chronic pulmonary obstructive disease were independent predictors of MACE during 67 
long-term follow-up (all, p<0.001).  68 
Conclusions. Coronary artery bypass using the ISS-LITA-LCC-TAMR configuration 69 
resulted in satisfactory long-term results with low incidence of death and late events and 70 
may represent a technique of choice in selected CABG patients. Larger and long-term 71 
prospective studies are, however, warranted. 72 
Keywords. Internal Thoracic Artery; Arterial Myocardial Revascularization, Coronary 73 
artery bypass 74 
75 
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Introduction 76 
The use of the left internal thoracic artery (LITA) to revascularize the left anterior 77 
descending artery (LAD) has been acknowledged as the gold-standard for coronary 78 
artery bypass grafting (CABG) [1]. Moreover, the additional benefits of the use of the 79 
right internal thoracic artery (RITA) in a bilateral configuration (BITA) has previously 80 
been reported [2–5]. A major issue with BITA use, however, is the risk of sternal 81 
complications [6]. Furthermore, many surgeons claim there is not enough evidence to 82 
support the use of BITA, mainly due to the conflicting results reported from 83 
heterogeneous studies [6–8].  84 
 85 
The most recent surgical revascularization guidelines (2018 ESC/EACTS), for example, 86 
recommends the use of BITA on the LV coronary circulation as an optimal surgical 87 
option and should be considered (class IIa) for appropriate patients. Furthermore  88 
employment of the RA as an alternative conduit to the RITA (class IIa), with the 89 
skeletonized BITA may also be considered (class IIb) offering improved outcomes in 90 
patients with higher risk of infections [9]’ 91 
 92 
Since 1997 we have utilized a standardized CABG graft configuration for total arterial 93 
revascularization. This consists of the in-situ skeletonized BITA for left coronary 94 
circulation grafting (ISS-BITA-LCC) with, if necessary, a radial artery (RA) on the right 95 
coronary circulation in a total arterial myocardial revascularization (TAMR) 96 
configuration (ISS-BITA-LLC-TAMR).  97 
 98 
We report our experience over 20 years with this approach and hypothesize that the use 99 
of ISS-BITA-LLC-TAMR configuration leads to positive long-term (>20 years) 100 
outcomes in terms of survival, repeat revascularization and major adverse cardiac 101 
events. We also explored potential predictors of these events. 102 




         Methods 105 
 106 
Approval was received by the Institutional Ethical Committee due to the prospective 107 
analysis of the study according to National Laws (Italian law nr.11960, released on 108 
13/07/2004). Written consent was obtained from patients subjected to the surgical 109 
procedure and the treatment of data for scientific purposes.  110 
 111 
Patients were recruited for this study between January 1997 and December 2017 and 112 
data were collected prospectively in a dedicated database employed for this study. All 113 
centers involved in this study applied the same study protocol and patient selection 114 
process. Study practices were homogeneous and outcome assessments centralized. 115 
During the same period of time the total number of patients undergoing various 116 
techniques of TAMR was 15,124.  Patients receiving RITA on LAD, RITA on a right 117 
coronary branch, those with free or Y grafts, or those receiving a venous graft were 118 
excluded.  119 
 120 
At the follow-up, both instrumental and clinical data were prospectively recorded in the 121 
database: hospital, physician or outpatient records, telephone interviews with the 122 
patients themselves or family members were collected.  123 
 124 
Definitions and Study End Points 125 
 126 
Primary endpoints of this study were: 1) Late death. 2) Repeat coronary 127 
revascularization (percutaneous coronary intervention [PCI] or repeat CABG).   3) 128 
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MACE, including cardiac death, nonfatal myocardial infarction (MI) or angina, target 129 
vessel revascularization, stroke and heart failure.  130 
 131 
Postoperative myocardial infarction was diagnosed by troponin and ECG criteria [8]. 132 
The diagnostic and classification of diabetes mellitus (DM) were based on criteria 133 
suggested by the American Diabetes Association [10] and all patients with DM 134 
underwent strict glycemic control with preoperative continuous insulin infusion, insulin 135 
infusions during CPB and  postoperative (24-48 hours) maintenance of  blood glucose at 136 
<10 mmol/L. Obesity was classified [11] as class I for a Body Mass Index (BMI) 137 
between 30 and 34.9 kg/m2, class II for a BMI between 35 and 39.9 kg/m2, and class III 138 
for a BMI ≥ 40 kg/m2. Stroke was defined as a new onset of focal or global neurological 139 
deficit lasting more than 24 h. Definitions of chronic renal disease (CKD) and Chronic 140 
Obstructive Pulmonary Disease (COPD) were consistent with those of the Society of the 141 
Thoracic Surgeon Database. 142 
 143 
Surgical Technique 144 
Surgery was carried out as previously reported [12, 13]. Indication and contraindication 145 
for BITA was also the same as we have recently reported [13]: in summary patients with 146 
a reasonable life expectancy (>1year), those requiring minimization of aortic 147 
manipulation and the presence of at least two angiographically branches of the left 148 
coronary circulation which were graftable were included. Contraindications were: poorly 149 
controlled diabetes (defined as an uninterrupted HbA1c >8.0% for ≥1 year despite 150 
standard care [14], class III obesity, evolving or acute (6 hours to 7 days) myocardial 151 
infarction. 152 
 153 
The target for skeletonized in situ LITA was the LAD and its branches. All patients had 154 
RITA on a left-sided target: in patients where two graftable branches were available, the 155 
branch with the larger perfusion area was selected; if both branches had identical 156 
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perfusion areas, the distal branch was selected for RITA grafting, whilst the other vessel 157 
was re-vascularized with composite, sequential ITA grafts or other available conduits if 158 
required. In patients with heavily calcified aorta OPCAB-BITA represented first choice 159 
to reduce the operative risk.  160 
 161 
Care was taken throughout the surgery to keep the pleurae closed, to preserve the 162 
pericardiacophrenic artery branches and to spare the communicating bifurcation of the 163 
ITAs to the wall of the chest. In cases where a radial graft was planned, the artery was 164 
harvested from the non-dominant arm after a preoperative assessment of the palmar arch 165 
with the Allen test. Digital plethysmography was carried out if required. 166 
All interventions were carried out by four senior surgeons (M.B. E.P. G.S. and S.G.). 167 
 168 
Postoperatively, careful control of the glycemic values was undertaken by employing 169 
continuous insulin infusion, giving certain consideration to the higher risk of deep 170 
sternal wound infection in BIMA employment [13]  171 
 172 
Statistical Analysis. 173 
 174 
To address missing values (range 0.002- 0.005) we used fully conditional specification 175 
multiple imputation method (1,000 replications).  176 
Normality of data was assessed using the Kolmogorov-Smirnov test. Continuous data 177 
were summarized as mean (standard deviation) or median (twenty-fifth to seventy-fifth 178 
percentiles) in case of skewed distributions. Categorical variables were reported as 179 
counts and percentages and comparisons were carried out using Fisher’s exact test. 180 
Forty-two parameters (Supplemental Material, Online Material) were considered in 181 
the initial model. To enhance the accuracy of the model, the number of variables was 182 
reduced using variable clustering. All variables showing p < 0.2 at univariable analysis 183 
were introduced into multivariable analyses. 184 
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 185 
The Kaplan-Meier method and log-rank test were used for survival analysis. A Cox 186 
regression model was used to estimate predictors of death. The proportional hazard 187 
assumption was confirmed by use of Schoenfeld residuals. A competing risk analysis 188 
was used to avoid overestimation of the incidence of repeated revascularization and 189 
MACE. R, release 3.2.3 (R Foundation for Statistical Computing, Wien, Austria) 190 
software and “survival”, “cmprsk” and “forestplot” packages were utilized. Significance 191 
for hypothesis testing was set at the 0.05 two-tailed level. 192 
 193 
         Results 194 
In total, 1,325 patients underwent CABG by ISS-BITA-LLC-TAMR technique during 195 
the period of study and were included. During the same period of time the total number 196 
of patients undergoing various techniques of TAMR was 15,124. Preoperative 197 
characteristics are summarized in Table 1.  198 
 199 
962 patients underwent on-pump arrested heart CABG and 363 patients underwent off-200 
pump CABG. In the group undergoing on-pump CABG various types of myocardial 201 
protection strategies were employed in 355 patients: in the early stages of the study St 202 
Thomas’ crystalloid cardioplegia was employed whilst after 2009 Custodiol was 203 
utilized. Also, cold blood cardioplegia was utilized in 607 patients. 204 
 205 
Early Results 206 
Early mortality was 1.4% (n=19) and the causes are shown in Supplemental Material 207 
2, Online Material along with other early outcomes. Surgical data is given in Table 2. 208 
RITA was routed via the transverse sinus in 873 patients (66%) and behind the superior 209 
caval vein in 452 (34%). The number of distal anastomosis in patients undergoing off-210 
pump was 2.5±0.8 versus 2.6±0.9 in on-pump group (P=0.06). 211 
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 Thirty-three patients (2.5%) showed sternal wound infection and 12 (0.9%) of them 212 
required surgical treatment. Fifteen of these patients were diabetic, whilst 18 were not 213 
(p>0.05). Diabetes significantly increased mortality in patients with wound infection 214 
(9/15 60% vs. 0/18, p<0.0001).  215 
 216 
 217 
Main Outcomes 218 
There were 131 deaths during follow up (9.8%). Cumulative actuarial survival at 1, 5, 219 
10, 15 and 18 years was 99.4± 0.2%, 97.5±2.3%, 93.1±5.7%, 85.7±7.8% and 220 
62.6±9.3%, respectively (Figure 1A). When survival rates were further analyzed 221 
(Figure 1B-E) patients with LVEF≤ 35%, PVD, COPD (all, p<0.0001), ≥80 years 222 
(p=0.0002), and chronic kidney disease, (CKD, p=0.0001) all showed lower survival 223 
rates.  224 
 225 
One-hundred-forty-six patients (11.0%) underwent repeat revascularization for graft 226 
failure: 16 (10.9 %) had redo CABG whereas 130(89%) underwent PCI. Also, in 57 of 227 
these patients revascularization occurred on another non-previously revascularized 228 
vessel. Eighty-five patients experienced RA failure (20.7% of RA), 39 a RITA failure 229 
(2.9% of RITA) and 22 (1.6% of LITA). Cumulative incidence of repeat 230 
revascularization at 1, 5, 10, 15 and 18 years (Figure 2A) was 2.3± 0.4%, 4.2±0.6%, 231 
8.4±1.1%, 18.3±3.8% and 20.4± 5.5% respectively. Values were significantly higher in 232 
OPCAB and PVD patients (Figure 2B, C).  233 
 234 
Median follow-up (100% complete) was 103 months (IQR  61 to 189 months) and 235 
ranged from 1 to 245 months. Cumulative follow-up was 156,424 patient-years.  236 
 237 
Two-hundred-twenty-nine patients had MACE during the follow up (17.2%). 238 
Cumulative incidence of MACE was 2.6±0.4%, 5.1±0.7%, 11.3±2.1%, 26.3±6.4%, 239 
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32.4±8.0 % at 1, 5, 10, 15 and 18 years, respectively (Figure 3A). Cumulative incidence 240 
(Figure 3B-F) was higher in patients ≥ 80 years, with PVD, LVEF<35%, those 241 
undergoing off-pump surgery or with COPD. LVEF ≤ 35%, COPD, PVD (all, 242 
p<0.0001), CKD and age ≥80 years (p=0.002) were independent predictors of 243 
diminished long-term survival (Table 3). Competing risk analysis of PVD and OPCAB 244 
(both, p<0.001) predicted repeat revascularization whilst a number of factors were 245 
independent predictors of MACE (age ≥ 80 years, PVD, LVEF ≤ 35%, presence of 246 
OPCAB and COPD (all, p<0.001)) 247 
 248 
         Discussion 249 
 250 
The routine use of BITA has been hampered by a number of factors despite the reported 251 
benefits of a second ITA [3–6]. The majority of published studies are biased by 252 
significant differences including techniques, anastomose target and graft type.  253 
 254 
In this paper we present a prospective 20-year experience in a relatively homogeneous 255 
population using a standard TAMR technique including in-situ skeletonized BITA for 256 
revascularization of left coronary branches and, when necessary, radial artery grafting 257 
for right coronary revascularization (ISS-BITA-LCC-TAMR). 258 
 259 
In our population, incidence of long-term postoperative adverse outcomes was relatively 260 
low [6, 15], especially when considering duration of follow-up. We believe these results 261 
are likely linked to three technical factors:  a) TAMR graft configuration; b) in-situ 262 
BITA arrangement (no Y free grafts) with a relatively small number of sequential 263 
anastomoses to ensure, in most of patients, the whole arterial flow to the main targeted 264 
vessel; c) both thoracic arteries anastomosed to the left circulation with LAD targeted by 265 
LITA and RITA never crossing the posterior sternum. Total arterial revascularization 266 
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using BITA has previously been shown to be advantageous in terms of long-term 267 
survival, incidence of cardiovascular events, as well as reoperation and need for 268 
angioplasty [2, 16]. The influence of TAMR on outcomes is presumably linked to the 269 
higher over- time patency rate of arterial grafts and avoidance of vein graft 270 
atherosclerosis as well as the less extensive manipulation of the ascending aorta. It 271 
remains to be established whether, and how much, the positive influence of TAMR in 272 
our study dependent on the skeletonized technique graft design. Calafiore’s group [17] 273 
previously reported that the long-term patency rate of skeletonized and pedicled ITA 274 
grafts was similar whereas other studies [18, 19] have shown that skeletonization of the 275 
ITA can improve conduit flow with larger vessel diameter. The recent ART trial [6, 20] 276 
has demonstrated the absence of any mid-term (5-year) benefit from BITA and that 277 
skeletonized harvesting did not add any further benefit compared to pedicled ITAs. 278 
However, only 48% of their patients received a skeletonized ITA with different 279 
configurations and, perhaps more importantly, follow-up was short. This could, at least 280 
in part, account for the differences seen with our study, as a recent study demonstrated 281 
that the differences between BITA and SITA only starts to become evident after 5 years 282 
[15]. At this time point results will also be influenced by the progressive reduction in the 283 
patency of vein grafts not employed in our study. 284 
 285 
In-situ RITA has previously been shown to have similar patency rates as in-situ LITA 286 
[21, 22] hence, this configuration has the potential advantage that coronary bypass flow 287 
is dependent on both ITAs simultaneously, resulting in a lower risk of left ventricular 288 
hypo-perfusion. Other BITA configurations have significant drawbacks. The in-situ 289 
RITA to the LAD plus in-situ LITA to another left ventricular coronary artery leads to a 290 
high risk of damage during re-sternotomy [23]. The RITA as a free-graft has been 291 
demonstrated to have a low patency rate when this graft is connected proximally to the 292 
aorta [24]. In contrast,  attachment of the free RITA to the in-situ LITA (T or Y graft) 293 
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has previously been observed to improve patency [17]. This arrangement does not, 294 
however, apply to the principle that LV revascularization occurs from two different 295 
sources, which could represent a key issue for optimal revascularization. The in-situ 296 
LITA to LAD, and in-situ RITA to the other left coronary target vessel, avoids the 297 
difficulties of anastomosing a thin wall vessel (e.g. the free RITA) to a thick wall vessel 298 
(e.g. the aorta). Furthermore, it decreases the risks of injury in case of mediastinal 299 
revision or re-operation since both ITAs lie in a safe position, requiring a lower number 300 
of anastomoses being performed and, finally, offering the possibility to easily apply the 301 
“non-touch” principle, by using different graft configurations [3].  302 
 303 
Accumulating evidence suggests that the LAD and circumflex territory revascularization 304 
should take priority over the RCA (in the majority of cases), as this vessel is not the 305 
clinical equivalent of the left-sided coronary branches [25, 26]. Nevertheless, a recent 306 
report failed (5) to identify differences in survival, repeat revascularization or combined 307 
outcomes between patients receiving RITA on left or coronary circulation in accordance 308 
with previous patient cohorts [26, 27] that had shown no differences in long-term 309 
outcomes when the RITA was anastomosed to the right or left coronary circulation. In 310 
contrast with these findings, other reports have suggested RITA grafting to the right 311 
coronary artery system may be less beneficial than to the left coronaries [20, 28]. 312 
Additionally, OPCAB was associated with increased risk of repeated coronary 313 
revascularization and MACE. According to our experience, OPCAB has to be taken into 314 
consideration in terms of risk of events during the follow-up period. This confirms 315 
previous data showing reduced graft patency, increased risk of cardiac re-intervention 316 
and death in CABG patients [29]. We can presume that among low-risk patients, adverse 317 
events related to cardiopulmonary bypass are rare and “technical adverse events”, such 318 
as incomplete revascularization, diminished graft patency or reduced accuracy of 319 
anastomosis related to the technical challenge of OPCAB, may be responsible for the 320 
negative outcome. On the other hand, amongst higher-risk patients, CPB- and aortic 321 
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manipulation- related events are more common and may outweigh technical adverse 322 
events. This may not be increased in higher-risk patients, since most patient 323 
comorbidities do not mean that OPCAB is more difficult to perform. Our findings must, 324 
however, be interpreted with caution, taking into consideration that the poorer outcome 325 
in OPCAB might be a result of higher disease burden. Furthermore, OPCAB techniques 326 
and facilitating devices have evolved over time hence our results may also be affected 327 
by our learning curve. Even taking this into account,  the present findings suggest a 328 
“balanced” patient-centric approach should be utilised as has been advocated even by 329 
the ESC/EACTS in their 2018 Guidelines [9] with the balance shifted more towards 330 
OPCAB   in patients with high risk of stroke, renal dysfunction, blood transfusion, 331 
respiratory failure and AF development as also suggested by the ISMIS Consensus 332 
Conference [29]. 333 
 334 
Finally, the link of diabetes to DSWI has been extensively studied and the prevalence of 335 
diabetes has been found to be three times higher among patients with DSWI than those 336 
without [2, 4, 6, 20] despite the fact that this patient population may have the most to 337 
gain from BITA grafting. Our data show that, with the skeletonized harvesting 338 
technique, diabetic patients did not have a significantly higher associated risk of DSWI 339 
although the mortality was significantly increased when patients presented with diabetes 340 
(60%, p<0.0001). This is in accordance with other studies [3, 4] and could be explained 341 
by the aggressive treatment received by our patients with well-established DM who are 342 
referred for CABG surgery (intravenous insulin infusion). An alternative hypothesis, 343 
however, could be that this is related to the accurate ITAs skeletonized harvesting 344 
technique where collateral blood flow to the sternum is preserved.  345 
In Figure 4 we represent visually the advantage of the present surgical strategy in term 346 
of patients’ survival: in this graph we compare long term survival with that of the ART 347 
trial[6] and of two other recent large studies [5, 30] with long-term follow-up employing 348 
only one thoracic artery and saphenous vein for myocardial revascularization 349 
Bonacchi. et al. 
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         350 
         351 
 Limitations 352 
 353 
A number of  limitations need to be acknowledged, however. Firstly, the homogeneous 354 
population (representing one of the main strength of the paper) is also a drawback since 355 
it may introduce a selection bias (i.e. exclusion of with RITA on RCA because of 356 
ungraftable highly diseased circumflex artery, patients with a second ITA with 357 
additional saphenous vein grafts. etc.).  Hence, we cannot exclude that this may 358 
contribute to the positive outcomes in this study, although the main risk factors of our 359 
BITA patients are comparable to those reported in previous studies [20]. 360 
 361 
Secondly, the study was underpowered by the low event rate. To overcome this 362 
limitation and increase power of the study we employed a variable-reduction method in 363 
our analysis. Fourthly, a direct comparison between single and double ITA as well as 364 
skeletonized vs. non-skeletonized technique was not carried out nor did we examine the 365 
true influence of skeletonized technique on long-term outcomes. Although these are all 366 
important points, they were points were beyond the main aim(s) of the present study. 367 
Thirdly, the target vessels were determined mainly by the perfusion area of the recipient 368 
artery and not selected randomly which may have introduced a bias. Finally, 369 
postoperative angiography was not routinely obtained meaning graft patency was 370 
unknown.  371 
 372 
Conclusions 373 
Coronary artery bypass using ISS-LITA-LCC-TAMR configuration resulted in 374 
satisfactory long-term results with low incidence of death and late events. Although our 375 
data does not provide a final answer regarding the potential benefits of using this 376 
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approach in all patients, our findings encourage the use of this technique in selected 377 
CABG patients. 378 
 379 
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 385 
Table 1. Patient Characteristics (n=1,325). 
 
Females 284 (21.4%) 
Mean age (years) 65.7r12.3 
Range 28-87 
Diabetes 329 (24.8%) 
Hypertension 946 (65,3%) 
Smoking 414 (71,4%) 
Dyslipidemia 564 (42.6%) 
CKD  
Creatinine 120-250 69 (5.2) 
Creatinine >250 38 (2.8) 
Dialysis 16 (1.2) 
Previous CVD 42 (3.2%) 
PVD 111 (8.4%) 
COPD  
 Mild- FEV1<50% predicted 79 (5.9 %) 
Moderate- FEV1<50-59 predicted 43 (3.2%) 
Moderate- FEV1<50-59 predicted 5 (0.3%) 
NYHA 1.7r0.9 
CCS 3.2r0.8 
Stable angina 759 (57.3%) 
Unstable angina 566 (42.7%) 
Prior myocardial infarction 712 (53.7%) 
Prior coronary angioplasty 428 (32.3%) 
Preoperative IABP 168 (12.6) 
Heavily calcified aorta 123 (9.3%) 
Coronary angiography data  
Three- vessel disease 925 (69.8%) 
Two-vessels disease 329 (24.8%) 
Left main coronary artery stenosis 441 (33.3%) 
LVEF 51.6r9.3 
LVEF ≤ 35% 301 (22.7%) 
EUROSCORE II 2.9r0.8 
STS Score   
 
3.6r2.7 
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Data are shown as mean r SD or numbers (percentage). Abbreviations: CKD: Chronic Renal Disease; 386 
CVD: Cerebrovascular Disease; PVD: Peripheral Vascular Disease; COPD: Chronic Obstructive 387 
Pulmonary Disease; FEV1: Forced Expiratory Volume in 1 second; NYHA: New Heart Association 388 
functional class; CCS: Canadian Cardiovascular Society angina class; IABP: Intra-aortic Balloon 389 
Pump; LVEF: Left Ventricular Ejection Fraction; STS: Society of Thoracic Surgeons. Heavily 390 
calcified aorta: Aorta with the ascending portion circumferentially calcified, detected at Thoracic Rx 391 
Thoracic TC Scan or detected manually during the surgical inspection at the operation time. 392 
 393 
394 
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 395 
Data are shown as mean r SD or numbers (percentage). Abbreviations: LITA= Left 396 
Internal Thoracic Artery; DA= diagonal branch of left descending artery; LAD: Left 397 
Descending Artery; RITA= Right Internal Thoracic Artery; IA= Intermediate artery; 398 
OM= obtuse marginal artery; PL= Postero-Lateral branch of the circumflex artery; 399 
RCA= Right Coronary Artery; DSWI= deep sternal wound infection. 400 
 401 
402 
Table 2. Operative Data (n=1,325). 
 
Urgent/Emergent 379 (28.6%) 
REDO 77 (5.8%) 
Cardiopulmonary bypass time (minutes) 83.7r21.3 
Aortic cross-clamping time (minutes) 64.6r16.4 
Off-pump coronary artery bypass grafting 363 (27.4%) 
Number of distal anastomoses per patients 2.6r0.7 
Coronary artery endarterectomy 104 (7.8%) 
Sequential anastomoses in-situ LITA-LAD-DA 365 (27.5%) 
Sequential anastomoses in-situ LITA-DA-LAD 257 (19.4%) 
RITA Grafted to the IA 238 (18%) 
RITA Grafted to the OM 822 (62%) 
RITA Grafted to the PL 265 (20%) 
Sequential anastomoses in-situ RITA 19 (1.4%) 
Radial artery on RCA or one of its branches  410 (30.9%) 
  
  












































Abbreviations: HR: Hazard Ratio; DM: Diabetes Mellitus; COPD: Chronic Obstructive Pulmonary Disease; LVEF: Left 445 
Ventricular Ejection Fraction; CKD: Chronic Renal Disease; PVD: Peripheral Vascular Disease; ID-DM: Insulin Dependent 446 
Diabetes Mellitus; MACE: Major Adverse Cardiovascular Events; OPCAB: Off-Pump Coronary Artery Bypass. CVD: 447 




Table 3. Predictors of Main Outcomes. 
 HR 95% CI p 
Death    
LVEF<35% 11.71 5.65 to 24.27 <0.001 
COPD 4.27 2.37 to 7.67 <0.001 
PVD 14.84 6.70 to 32.89 <0.001 
CKD 3.40 1.82 to 6.37 <0.001 
Age≥80 years 2.79 1.64 to 4.75 <0.001 
DM 2.53 0.79 to 17.52 0.089 
ID-DM 3.28 0.90 to 31.86 0.069 
3-vessel Disease 2.76 0.61 to 18.83 0.093 





SHR 95% CI p 
OPCAB 17.42 6.35 to 47.32 <0.001 
PVD  8.78 4.23 to 19.34 <0.001 
    
MACE 
Age≥80 years 2.45 1.75 to 3.94 <0.001 
PVD 8.55 4.23 to 14.88 <0.001 
LVEF < 35% 14.21 6.47 to 30.54 <0.001 
OPCAB 2.12 1.07 to 3.54 <0.001 
COPD 1.89 1.13 to 3.41 <0.001 
Female sex 2.05 0.67 to 7.77 0.069 
CVD 3.04 0.75 to 25.05 0.064 
CKD 4.55 0.67 to 10.85 0.078 
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Figure Legends 543 
 544 
 545 
Central Picture. Picture summarizing the surgical strategy applied. 546 
 547 
Figure 1. Overall Survival and Survival in sub-groups of patients. Abbreviations: LVEF: Left 548 
Ventricular Ejection Fraction; PVD: Peripheral Vascular Disease; COPD: Chronic 549 
Obstructive Pulmonary Disease; CKD: Chronic Kidney Disease. Of note is the Kaplan Meir 550 
curves are plotted from 70-100% survival probability in Panel A and from 10-100% survival 551 
probability in Panel E. All other curves are plotted from 0-100% survival probability.  552 
 553 
Figure 2. Total cumulative incidence of repeat revascularization and stratified by groups. 554 
Abbreviations: OPCAB: Off-pump Coronary (Artery) Bypass; PVD: Peripheral Vascular 555 
Disease. 556 
 557 
Figure 3. Total cumulative incidence of MACE and by sub-groups. Abbreviations: PVD: 558 
Peripheral Vascular Disease; LVEF: Left Ventricular Ejection Fraction; OPCAB: Off-pump 559 
Coronary (Artery) Bypass; COPD: Chronic Obstructive Pulmonary Disease; 560 
 561 
Figure 4. Graphic comparison demonstrating the benefit obtained whit Bilateral-ITA vs 562 
Monolateral-ITA: our long-term survival curve is related with the ART trial[6] and another 563 
two Monolateral-IMA long-term studies survival curves [5, 30]. Of note is the Kaplan Meir 564 
curves are plotted from 75-100% survival probability 565 
566 
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 567 
Abbreviation List 568 
 569 
 570 
I SS-LITA-LCC-TAMR: in-situ skeletonized bilateral thoracic artery for left coronary circulation 571 
LITA: Left Internal Thoracic Artery 572 
RITA Right Internal Thoracic Artery 573 
BITA: Bilateral Internal Thoracic Artery 574 
RA: Radial Artery 575 
SVG: Saphenous venous graft 576 
CKD: Chronic Renal Disease; 577 
CVD: Cerebrovascular Disease; 578 
PVD: Peripheral Vascular Disease; 579 
COPD: Chronic Obstructive Pulmonary Disease; 580 
FEV1: Forced Expiratory Volume in 1 second; 581 
NYHA: New Heart Association functional class; 582 
CCS: Canadian Cardiovascular Society angina class; 583 
IABP: Intra-aortic Balloon Pump; 584 
LVEF: Left Ventricular Ejection Fraction; 585 
STS: Society of Thoracic Surgeons. 586 
DM: Diabetes Mellitus; 587 
ID-DM: Insulin Dependent Diabetes Mellitus; 588 
MACE: Major Adverse Cardiovascular Events; 589 
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